{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$5.82 vs. cons $5.74",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$11.60B vs. cons $11.58B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "IN-LINE",
      "answer": "pred ~3.2% vs. cons 3.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$24.88 midpoint vs. cons $24.94 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 revenue guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$47.70B midpoint vs. cons $47.73B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% midpoint vs. cons 3.4% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted operating-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~70 bps vs. cons 70 bps (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.5,
  "day5_path": "FADE",
  "day5_rationale": "A ~$0.08 EPS beat versus $5.74 consensus and ~3.2% organic growth versus 3.0% should support an initial positive reaction, but a largely unchanged FY2026 EPS midpoint of ~$24.88 versus $24.94 consensus leaves modest implicit out-period pressure and limits estimate-revision follow-through.",
  "day5_confidence": "MEDIUM"
}